BioHorizons Company Profile

Background

Overview

BioHorizons, established in 1994 at the University of Alabama at Birmingham, has evolved into one of the world's leading dental implant companies. The company specializes in advanced dental implant technologies and tissue regeneration products, offering comprehensive solutions for tooth replacement and oral reconstruction. With a global presence, BioHorizons serves customers in over 85 markets worldwide.

Mission and Vision

BioHorizons is dedicated to improving the quality of life for patients with missing teeth by providing clinicians with innovative and evidence-based dental implants and tissue regeneration products. The company's core values include respect for the individual, service to customers, efficiency and profitability, pursuit of excellence, and integrity.

Key Strategic Focus

Core Objectives

BioHorizons aims to lead in dental implant innovation, focusing on developing scientifically proven products that enhance surgical and aesthetic outcomes. The company emphasizes evidence-based research, continuous product development, and comprehensive support for dental professionals.

Areas of Specialization

The company specializes in dental implant systems, biologic products, and digital solutions, offering a comprehensive portfolio that addresses various surgical and prosthetic indications.

Key Technologies Utilized

Laser-Lok® Technology: A proprietary microchannel surface technology that promotes both bone and soft tissue attachment, enhancing implant stability and esthetics.

Digital Treatment Planning: Advanced digital solutions that assist clinicians in precise implant placement and treatment planning.

Primary Markets Targeted

BioHorizons targets dental professionals and patients globally, with a significant presence in North America, Europe, South America, Asia, Africa, and Australia.

Financials and Funding

Funding History

In 2013, Henry Schein, Inc. acquired a 60% equity stake in BioHorizons for approximately $145 million. The full acquisition was completed in 2018, integrating BioHorizons into Henry Schein's Global Oral Reconstruction Group.

Total Funds Raised

Specific details regarding the total funds raised by BioHorizons are not publicly disclosed.

Notable Investors

Henry Schein, Inc. is the primary investor, having acquired BioHorizons in two stages: a 60% stake in 2013 and full ownership in 2018.

Utilization of Capital

The capital has been utilized for product development, global expansion, and integration into Henry Schein's operations to enhance distribution and support for dental professionals.

Pipeline Development

Key Pipeline Candidates

BioHorizons continually develops new implant systems and biologic products to meet evolving clinical needs. Specific details on pipeline candidates are not publicly disclosed.

Stages of Development

The company is involved in ongoing research and development, with products at various stages from conceptualization to market introduction.

Target Conditions

BioHorizons focuses on conditions related to tooth loss and oral reconstruction, aiming to provide solutions for a wide range of dental implant procedures.

Anticipated Milestones

While specific timelines are not publicly disclosed, BioHorizons continues to innovate and expand its product offerings to meet the needs of dental professionals and patients.

Technological Platform and Innovation

Proprietary Technologies

Laser-Lok® Technology: A unique surface treatment that promotes both bone and soft tissue attachment, enhancing implant stability and esthetics.

Significant Scientific Methods

Evidence-Based Research: BioHorizons invests in extensive clinical studies to validate the effectiveness of its products, ensuring high success rates and reliability.

Leadership Team

Key Executives

Steve Boggan: President and CEO since 1999, with a background in biomedical engineering.

Todd Strong: Executive Vice President and COO, with the company since its inception.

Leadership Changes

No significant leadership changes have been publicly reported in recent years.

Competitor Profile

Market Insights and Dynamics

The dental implant market is experiencing steady growth, driven by increasing demand for tooth replacement solutions and advancements in implant technologies. BioHorizons faces competition from several key players in the industry.

Competitor Analysis

Dentsply Sirona: A leading competitor with a broad product portfolio in dental implants and related products.

Zimmer Biomet: A significant player in the dental implant market, offering a range of implant systems and biologic products.

Straumann: A global leader in dental implants, known for its innovative implant solutions and biologic products.

Strategic Collaborations and Partnerships

BioHorizons has been part of Henry Schein, Inc. since 2018, enhancing its distribution capabilities and access to a broader customer base.

Operational Insights

BioHorizons' focus on innovation, quality manufacturing, and comprehensive customer support differentiates it in the competitive landscape. The company's commitment to evidence-based products and global reach positions it as a strong competitor in the dental implant industry.

Strategic Opportunities and Future Directions

Strategic Roadmap

BioHorizons continues to invest in research and development to expand its product offerings and improve patient outcomes. The company aims to leverage its position within Henry Schein to enhance distribution and support for dental professionals worldwide.

Future Business Directions

The company is focused on expanding its global presence, introducing innovative implant systems, and providing comprehensive solutions that address the evolving needs of dental professionals and patients.

Opportunities for Expansion

BioHorizons sees opportunities in emerging markets and through strategic partnerships to further its mission of improving the quality of life for patients with missing teeth.